Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$479.06 - $630.38 $191 Million - $251 Million
398,500 New
398,500 $197 Million
Q1 2024

May 13, 2024

BUY
$473.42 - $539.26 $36.9 Million - $42.1 Million
78,000 New
78,000 $41.9 Million
Q3 2022

Nov 10, 2022

SELL
$321.25 - $373.84 $41.1 Million - $47.8 Million
-127,900 Reduced 66.3%
65,000 $22.1 Million
Q2 2022

Aug 10, 2022

SELL
$300.57 - $336.42 $2.13 Million - $2.39 Million
-7,100 Reduced 3.55%
192,900 $62.9 Million
Q1 2022

May 16, 2022

BUY
$244.61 - $310.48 $48.4 Million - $61.4 Million
197,800 Added 8990.91%
200,000 $61.2 Million
Q3 2020

Nov 12, 2020

BUY
$140.89 - $159.9 $28,177 - $31,980
200 Added 10.0%
2,200 $328,000
Q1 2020

May 01, 2020

SELL
$115.75 - $170.96 $1.04 Million - $1.54 Million
-9,000 Reduced 81.82%
2,000 $271,000
Q4 2019

Feb 14, 2020

BUY
$130.23 - $153.27 $1.43 Million - $1.69 Million
11,000 New
11,000 $1.52 Million

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $89.3B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.